Literature DB >> 28727918

Sensitive and Quantitative Detection of Anti-Poly(ethylene glycol) (PEG) Antibodies by Methoxy-PEG-Coated Surface Plasmon Resonance Sensors.

Peng Zhang1, Fang Sun1, Hsiang-Chieh Hung1, Priyesh Jain1, Kasey Joanne Leger2, Shaoyi Jiang1.   

Abstract

Pre-existing and induced anti-poly(ethylene glycol) (PEG) antibodies (abs) have been shown to be related with limitation of therapeutic efficacy and reduction in tolerance of several therapeutic agents. However, the current methods to detect anti-PEG abs are tedious and usually lack quantification. A facile, rapid, sensitive, and reliable technique to detect anti-PEG abs is highly desired in both research and clinic settings. In this work, we have presented a surface plasmon resonance (SPR) biosensor technique for the detection of anti-PEG abs and compared three PEG surface chemistries. Methoxy-PEG (mPEG) 5k was found to have the best performance. The detection of anti-PEG abs directly from diluted blood serum was achieved within 40 min. Detection sensitivity is as good as or better than enzyme-linked immunosorbent assay (ELISA). Furthermore, different antibody isotypes can be quantitatively differentiated by adopting secondary antibodies. A pilot study has been performed to analyze clinical blood samples using this technology, demonstrating its potential as a convenient and powerful method to prescreen and monitor anti-PEG abs in the patients before or after they receive treatment with PEG-containing drugs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28727918      PMCID: PMC5750323          DOI: 10.1021/acs.analchem.7b02447

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  24 in total

Review 1.  Effect of pegylation on pharmaceuticals.

Authors:  J Milton Harris; Robert B Chess
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

2.  Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.

Authors:  XinYu Wang; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  J Control Release       Date:  2007-02-24       Impact factor: 9.776

3.  Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity.

Authors:  Peng Zhang; Fang Sun; Caroline Tsao; Sijun Liu; Priyesh Jain; Andrew Sinclair; Hsiang-Chieh Hung; Tao Bai; Kan Wu; Shaoyi Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-14       Impact factor: 11.205

4.  Protein adsorption on oligo(ethylene glycol)-terminated alkanethiolate self-assembled monolayers: The molecular basis for nonfouling behavior.

Authors:  Lingyan Li; Shengfu Chen; Jie Zheng; Buddy D Ratner; Shaoyi Jiang
Journal:  J Phys Chem B       Date:  2005-02-24       Impact factor: 2.991

Review 5.  Anti-PEG immunity: emergence, characteristics, and unaddressed questions.

Authors:  Qi Yang; Samuel K Lai
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-02-23

6.  Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial.

Authors:  Nicola Longo; Cary O Harding; Barbara K Burton; Dorothy K Grange; Jerry Vockley; Melissa Wasserstein; Gregory M Rice; Alejandro Dorenbaum; Jutta K Neuenburg; Donald G Musson; Zhonghua Gu; Saba Sile
Journal:  Lancet       Date:  2014-04-14       Impact factor: 79.321

7.  Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.

Authors:  Tatsuhiro Ishida; Masako Ichihara; XinYu Wang; Kenji Yamamoto; Junji Kimura; Eiji Majima; Hiroshi Kiwada
Journal:  J Control Release       Date:  2006-03-03       Impact factor: 9.776

Review 8.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

9.  Zwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasma.

Authors:  Jon Ladd; Zheng Zhang; Shengfu Chen; Jason C Hower; Shaoyi Jiang
Journal:  Biomacromolecules       Date:  2008-04-01       Impact factor: 6.988

10.  Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.

Authors:  Peter E Lipsky; Leonard H Calabrese; Arthur Kavanaugh; John S Sundy; David Wright; Marsha Wolfson; Michael A Becker
Journal:  Arthritis Res Ther       Date:  2014-03-04       Impact factor: 5.156

View more
  5 in total

1.  Architectural Modification of Conformal PEG-Bottlebrush Coatings Minimizes Anti-PEG Antigenicity While Preserving Stealth Properties.

Authors:  Daniel Y Joh; Zackary Zimmers; Manav Avlani; Jacob T Heggestad; Hakan B Aydin; Nancy Ganson; Shourya Kumar; Cassio M Fontes; Rohan K Achar; Michael S Hershfield; Angus M Hucknall; Ashutosh Chilkoti
Journal:  Adv Healthc Mater       Date:  2019-03-25       Impact factor: 9.933

Review 2.  In Pursuit of Zero 2.0: Recent Developments in Nonfouling Polymer Brushes for Immunoassays.

Authors:  Jacob T Heggestad; Cassio M Fontes; Daniel Y Joh; Angus M Hucknall; Ashutosh Chilkoti
Journal:  Adv Mater       Date:  2019-11-29       Impact factor: 30.849

Review 3.  Biocompatibility Evolves: Phenomenology to Toxicology to Regeneration.

Authors:  Lars Crawford; Meghan Wyatt; James Bryers; Buddy Ratner
Journal:  Adv Healthc Mater       Date:  2021-04-07       Impact factor: 11.092

Review 4.  Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review.

Authors:  Kouichi Shiraishi; Masayuki Yokoyama
Journal:  Sci Technol Adv Mater       Date:  2019-04-15       Impact factor: 8.090

5.  Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes.

Authors:  Yuan-Chin Hsieh; Hsin-Ell Wang; Wen-Wei Lin; Steve R Roffler; Ta-Chun Cheng; Yu-Cheng Su; Jia-Je Li; Chao-Cheng Chen; Chun-Han Huang; Bing-Mae Chen; Jaw-Yuan Wang; Tian-Lu Cheng; Fang-Ming Chen
Journal:  Theranostics       Date:  2018-05-09       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.